Novus Therapeutics
Why Robinhood?
You can watch NVUS and buy or sell other stocks, ETFs, and their options commission-free!About NVUS
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in development of therapies to protect transplanted organs and prevent rejection. The firm also focuses on development of therapy to treat amyotrophic lateral sclerosis.
NVUS Key Statistics
Stock Snapshot
As of today, Novus Therapeutics(NVUS) shares are valued at $9.30. The company's market cap stands at 705.42M, with a P/E ratio of -4.49.
On 2026-07-28, Novus Therapeutics(NVUS) stock opened at —, reached a high of —, and a low of —.
Novus Therapeutics(NVUS) shares are trading with a volume of 0, against a daily average of 1.64M.
In the last year, Novus Therapeutics(NVUS) shares hit a 52-week high of $4.60 and a 52-week low of $1.35.
In the last year, Novus Therapeutics(NVUS) shares hit a 52-week high of $4.60 and a 52-week low of $1.35.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.